- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
CORONA Remedies reports Q1 FY27 revenue up 21.9% to ₹422.4 Cr and PAT up 30.1% to ₹60.1 Cr. Company is the fastest growing among top 30 IPMs and ranks 26th. New EU-GMP female hormone plant operational.